Rise Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $69.8K | Buy |
800
+20
| +3% | +$1.75K | 0.03% | 200 |
|
2025
Q1 | $53.3K | Buy |
780
+14
| +2% | +$956 | 0.02% | 217 |
|
2024
Q4 | $59.6K | Sell |
766
-27
| -3% | -$2.1K | 0.03% | 200 |
|
2024
Q3 | $53.2K | Sell |
793
-44
| -5% | -$2.95K | 0.03% | 227 |
|
2024
Q2 | $94.9K | Hold |
837
| – | – | 0.05% | 153 |
|
2024
Q1 | $116K | Buy |
837
+201
| +32% | +$27.9K | 0.06% | 134 |
|
2023
Q4 | $78.9K | Sell |
636
-24
| -4% | -$2.98K | 0.06% | 122 |
|
2023
Q3 | $61.6K | Buy |
660
+528
| +400% | +$49.3K | 0.05% | 124 |
|
2023
Q2 | $17K | Sell |
132
-60
| -31% | -$7.71K | 0.01% | 258 |
|
2023
Q1 | $22.3K | Hold |
192
| – | – | 0.02% | 238 |
|
2022
Q4 | $21.7K | Hold |
192
| – | – | 0.02% | 238 |
|
2022
Q3 | $15K | Hold |
192
| – | – | 0.01% | 281 |
|
2022
Q2 | $14K | Hold |
192
| – | – | 0.01% | 279 |
|
2022
Q1 | $25K | Hold |
192
| – | – | 0.02% | 218 |
|
2021
Q4 | $25.8K | Buy |
+192
| New | +$25.8K | 0.02% | 216 |
|